| 保存条件 | Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month. |
| 数量 | 货期:1-2天 |
| 供应商 | MedChemExpress LLC |
| CAS号 | 436133-68-5 |
| 规格 | 10 mM * 1 mL/10 mg/50 mg/100 mg/200 mg |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 436133-68-5
MCE 国际站:Kobe0065
产品活性:Kobe0065 是一种新颖的,有效的 Ras-Raf 相互作用抑制剂,能够完全抑制 H-Ras·GTP 与 c-Raf-1 RBD 的结合,Ki 值为 46±13 μM。
研究领域:GPCR/G Protein | Apoptosis
In Vitro: Kobe0065-family compounds bind to Ras•GTP and exhibit antiproliferative activity toward cancer cells carrying the activated ras oncogenes. The compounds efficiently inhibit the interaction of Ras•GTP with their multiple effectors including Raf, PI3K, and RalGDS and a regulator/effector Sos and show rather broad binding specificity toward various Ras family small GTPases, which may account for their higher potency at the cellular level compared with that of the in vitro binding inhibition. The phosphorylation of downstream kinases MEK and ERK is effectively attenuated by 20 μM Kobe0065 and Kobe2602 in NIH3T3 cells transiently expressing H-RasG12V.
In Vivo: Kobe0065 and Kobe2602 exhibit antitumor activity on a xenograft of human colon carcinoma SW480 cells carrying the K-ras(G12V) gene by oral administration.
相关产品:Apoptosis Compound Library | GPCR/G Protein Compound Library | Glutamine Metabolism Compound Library | Ferroptosis Compound Library | Anti-Cancer Compound Library | Bioactive Compound Library Plus | MG-132 | LY294002 | Doxorubicin hydrochloride | Bafilomycin A1 | Paclitaxel | Y-27632 dihydrochloride | Sorafenib | SP600125 | Staurosporine | Angiotensin II human | 5-Fluorouracil | Trametinib | Acetylcysteine | MK-2206 dihydrochloride | Bortezomib | Tamoxifen | AMG-510 | Gemcitabine | Pexidartinib | 2-Deoxy-D-glucose | Temozolomide | Ruxolitinib | Verteporfin | Decitabine | BAY 11-7082 | Mdivi-1 | Etoposide | DAPT | Dasatinib
品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供最全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪制药及生命科学研究进展,为您提供全球活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。